Status:
COMPLETED
PET Imaging and Bariatric Surgery
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Obesity, Morbid
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2/3) and other st...
Detailed Description
The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2/3) and other st...
Eligibility Criteria
Inclusion
- Ages 18-60 years
- BMI equal to or greater than 40, or equal to or greater than 35 if there are 2 or more co-morbidities
- Weight less than 350 pounds
Exclusion
- History of substance abuse,including but not limited to alcohol, cocaine, marijuana, heroin, nicotine
- History of psychiatric disorders
- Use of any antidepressants or psychotropics in the past 12 months
- Diabetes Mellitis
- Positive pregnancy test
- Any condition felt by the PI or co-investigators to interfere with the individual's ability to complete the study
- Subjects on medications for the last 3 months, such as sibutramine, which could affect the quality of the study, as determined by the PI
- Inability to travel to Nashville, TN four times
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT00801827
Start Date
January 1 2007
End Date
June 1 2012
Last Update
March 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232